Mackenzie Financial »

Beam Therapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.4M 186k 34.32
2021-12-31 $211k 2.6k 79.80
2021-09-30 $240k 2.8k 87.08
2021-06-30 $213k 1.7k 128.86

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Toronto-Dominion Bank/The Common Stock (TD)
State Street Corp Etp (SPY)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Bank of Montreal Common Stock (BMO)
Alphabet Common Stock (GOOGL)
Canadian Pacific Kansas City L Common Stock (CP)
Microsoft Corp Common Stock (MSFT)
Agnico Eagle Mines Common Stock (AEM)
Canadian Imperial Bank of Comm Common Stock (CM)
Manulife Financial Corp Common Stock (MFC)
Enbridge Common Stock (ENB)
Canadian Natural Resources Common Stock (CNQ)
Amazon.com Common Stock (AMZN)

View all positions for Mackenzie Financial

Top funds holding Beam Therapeutics

FMR
Farallon Capital Management
ARK Investment Management
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Arch Venture Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
T. Rowe Price Associates
Geode Capital Management
Dimensional Fund Advisors
Contrarius Group Holdings

View all funds holding Beam Therapeutics